Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 1/20 | 0.34 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.31 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.30 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.30 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.30 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.30 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.30 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31423902 | 0.90 | NTRK1 (0.34) | NTRK1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL31423933 | 0.90 | NTRK1 (0.34) | NTRK1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL31423948 | 0.90 | NTRK1 (0.34) | NTRK1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL31423937 | 0.90 | NTRK1 (0.34) | NTRK1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL31423966 | 0.90 | NTRK1 (0.34) | NTRK1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL25277898 | 0.86 | ATR (0.35) | PIK3CAMAPK1 | |
| SCHEMBL31423943 | 0.84 | NTRK1 (0.35) | NTRK1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL31458686 | 0.82 | JAK2 (0.35) | MAPK1 | |
| SCHEMBL31458631 | 0.79 | JAK1 (0.33) | PIK3CAMAPK1 | |
| SCHEMBL31458628 | 0.79 | PRKDC (0.30) | PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025096061-A1 | CDK2 INHIBITORS AND USES THEREOF | ODYSSEY THERAPEUTICS, INC. (US) | 2025-05-08 | — | — | WO | disclosed |